Niagen Bioscience (NAGE)

• Market cap: $520M
• 1 day: -1.66%
• 5 days: 1.24%
• 1 month: -9.19%
• 3 months: -32.15%
• 6 months: -53.89%
• Year to date: 18.98%
• 1 year: 2.19%
• 5 years: 27.34%
• 10 years: 45.54%
• Sector: Healthcare
• Industry: Biotechnology

About: Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Employees: 104